Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Yung, Lai Ming ^a   Wong, Wing Tak ^a   Tian, Xiao Yu ^a   Leung, Fung Ping ^a   Yung, Lai Hang ^a   Chen, Zhen Yu ^a   Yao, Xiaoqiang ^a   Lau, Chi Wai ^a   Huang, Yu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; HYDROETHIDINE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN; SERINE; VALSARTAN; ACETYLCHOLINE; ANGIOTENSIN 2 RECEPTOR; DRUG DERIVATIVE; SCAVENGER; TETRAZOLE DERIVATIVE; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME PHOSPHORYLATION; ESTROGEN DEFICIENCY; FEMALE; FLUORESCENCE ANALYSIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSTMENOPAUSE; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

RATTUS;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; ENALAPRIL; ENDOTHELIUM, VASCULAR; ESTROGENS; FEMALE; FREE RADICAL SCAVENGERS; NADPH OXIDASE; NITRIC OXIDE; OVARIECTOMY; OXIDATIVE STRESS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; VALINE; VASODILATION;

EID: 79953221448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017437     Document Type: Article

References (31)

1. Wenger NK, Speroff L, Packard B, (1993) Cardiovascular health and disease in women. N Engl J Med 329: 247-256.
2. Nogawa N, Sumino H, Ichikawa S, Kumakura H, Takayama Y, et al. (2001) Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women. Menopause 8: 210-215.
3. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, et al. (1997) Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 95: 39-45.
4. Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, et al. (1998) Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97: 2197-2201.
5. Hinojosa-Laborde C, Craig T, Zheng W, Ji H, Haywood JR, et al. (2004) Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 44: 405-409.
6. Wassmann S, Baumer AT, Strehlow K, van Eickels M, Grohe C, et al. (2001) Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103: 435-441.
7. Lavi S, McConnell JP, Rihal CS, Prasad A, Mathew V, et al. (2007) Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 115: 2715-2721.
8. Elesber AA, Redfield MM, Rihal CS, Prasad A, Lavi S, et al. (2007) Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans. Am Heart J 153: 1081-1087.
9. Halligan SC, Murtagh B, Lennon RJ, Pumper GM, Mathew V, et al. (2004) Effect of long-term hormone replacement therapy on coronary endothelial function in postmenopausal women. Mayo Clin Proc 79: 1514-1520.
10. Wong CM, Yao X, Au CL, Tsang SY, Fung KP, et al. (2006) Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats. Vascul Pharmacol 44: 290-298.
11. Vitale C, Mercuro G, Cerquetani E, Marazzi G, Patrizi R, et al. (2008) Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 28: 348-352.
12. Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, et al. (2007) Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112: 417-428.
13. Yoshida K, Kobayashi N, Ohno T, Fukushima H, Matsuoka H, (2007) Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats. J Hypertens 25: 1633-1642.
14. Wassmann S, Wassmann K, Nickenig G, (2004) Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44: 381-386.
15. Ginnan R, Guikema BJ, Halligan KE, Singer HA, Jourd'heuil D, (2008) Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic Biol Med 44: 1232-1245.
16. Ono H, Minatoguchi S, Watanabe K, Yamada Y, Mizukusa T, et al. (2008) Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension. Hypertens Res 31: 271-279.
17. Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, et al. (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22: 2465-2475.
18. Li YQ, Ji H, Shen Y, Ding LJ, Zhuang P, et al. (2009) Chronic treatment with angiotensin AT1 receptor antagonists reduced serum but not bone TGF-beta1 levels in ovariectomized rats. Can J Physiol Pharmacol 87: 51-55.
19. Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, et al. (2009) Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 24: 241-250.
20. Malmqvist K, Kahan T, Dahl M, (2000) Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. Am J Hypertens 13: 504-511.
21. Wassmann K, Ghiassi A, Wassmann S, Bohm M, Nickenig G, (2006) AT1 receptor antagonism improves endothelial dysfunction in postmenopausal women. Maturitas 53: 176-183.
22. Yung LM, Leung FP, Yao X, Chen ZY, Huang Y, (2006) Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets 6: 1-19.
23. Hunyady L, Catt KJ, (2006) Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 20: 953-970.
24. Mehta PK, Griendling KK, (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-97.
25. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST, (2003) Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol 23: 38-44.
26. Imanishi T, Kobayashi K, Kuroi A, Mochizuki S, Goto M, et al. (2006) Effects of angiotensin II on NO bioavailability evaluated using a catheter-type NO sensor. Hypertension 48: 1058-1065.
27. Sumino H, Ichikawa S, Kanda T, Sakamaki T, Nakamura T, et al. (1999) Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin. Am J Hypertens 12: 1044-1047.
28. Ungvari Z, Wolin MS, Csiszar A, (2006) Mechanosensitive production of reactive oxygen species in endothelial and smooth muscle cells: role in microvascular remodeling? Antioxid Redox Signal 8: 1121-1129.
29. Tran D, Phoon S, Howes L, (2001) The effects of candesartan on vascular responses to angiotensin II and norepinephrine in normal volunteers. J Renin Angiotensin Aldosterone Syst 2: 199-203.
30. Phoon S, Howes LG, (2002) Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)- receptors. J Renin Angiotensin Aldosterone Syst 3: 36-39.
31. Hodgin JB, Knowles JW, Kim HS, Smithies O, Maeda N, (2002) Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice. J Clin Invest 109: 541-548.